A spokesperson for Eli Lilly, which makes tirzepatide-based competitors to Ozempic and Wegovy called Mounjaro and Zepbound, said Wednesday that it too had seen anecdotal commentary in publications about the potential use of GLP-1s for additional indications like addiction. But while the Indianapolis-based drugmaker continues to evaluate future development options for tirzepatide, the spokesperson said the company hadnt announced any plans to develop its medicines for those uses
If pharmacy transparency is important to you, and it probably should be, this is a factor worth weighing heavily in your decision
The Role of Hydration in Managing Nausea on GLP-1 Did you know these meds also affect your thirst drive
I was surprised and encouraged about all the positive impact the medication has on patients, specifically in reducing risk of cognitive decline
It beggars belief that over 88% of people with insurance coverage for GLP-1s for weight loss still face restrictions such as prior authorizations or step therapy, and of course, doctors love this